Tauns Laboratories, Inc. (JP:197A) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tauns Laboratories, Inc. has announced its participation in the Triple I for Global Health initiative, aiming to tackle health issues in low and middle-income countries through impact investments. The company is renowned for its rapid diagnostic test kits and has been actively contributing to global health solutions, particularly in the fight against tuberculosis. By leveraging 30 years of proprietary technology, Tauns strives to enhance global health and sustainability.
For further insights into JP:197A stock, check out TipRanks’ Stock Analysis page.